Home>Topics>>2 Deaths, 25% Plunge - And Still A Big Upside
2 Deaths, 25% Plunge - And Still A Big Upside
Healthcare Sector and Stocks Analysis from Seeking Alpha
Fri, 14 Feb 2014
By YCharts : By David J. Phillips Progenics Pharmaceuticals ( PGNX ) fell more than 25% in recent days, recovering slightly, after an abstract presented at the 2014 Genitourinary Cancers Symposium revealed that two patients receiving the company’s investigational antibody-drug conjugate (ADC) died ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.